Screener
Harmony Biosciences Holdings, Inc. HRMY Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net product revenue | $215,387 | $184,733 |
| Cost of product sold | 44,512 | 31,994 |
| Gross profit | 170,875 | 152,739 |
| Operating expenses: | ||
| Research and development | 69,383 | 34,540 |
| Sales and marketing | 31,694 | 30,711 |
| General and administrative | 32,507 | 31,243 |
| Total operating expenses | 133,584 | 96,494 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s gross profit?
- Harmony Biosciences Holdings, Inc. (HRMY) reported gross profit of $170.88M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s gross profit changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s gross profit increased by 11.9% year-over-year, from $152.74M to $170.88M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s gross profit?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s gross profit has grown at a 28.0% compound annual growth rate (CAGR), from $249.92M to $670.11M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Harmony Biosciences Holdings, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude